New liquid oral formulations of hydroxychloroquine: a physicochemical stability study
Hydroxychloroquine (HCQ) presents many drug properties that increase its therapeutic use. There are, indeed, different research pathways in numerous autoimmune, inflammatory, and infectious diseases, as well as in cancerology. HCQ is only marketed as HCQ sulfate in film-coated or coated tablets for...
Guardado en:
Autores principales: | Lebreton Vincent, Bourcier Blandine, Cosson Karine, Lagarce Frédéric, Spiesser-Robelet Laurence, Vrignaud Sandy |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/561c3cf312b54639b970bc2690cacafe |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Somatotype, the risk of hydroxychloroquine retinopathy, and safe daily dosing guidelines
por: Browning DJ, et al.
Publicado: (2018) -
Hydroxychloroquine serum concentration in coronavirus disease 2019 (COVID-19) patients: a retrospective study
por: Saadi Fatima Zohra, et al.
Publicado: (2021) -
Coding patterns used by ophthalmologists for hydroxychloroquine retinal toxicity
por: Chiu SY, et al.
Publicado: (2018) -
Incidence of and risk factors for chloroquine and hydroxychloroquine retinopathy in Thai rheumatologic patients
por: Tangtavorn N, et al.
Publicado: (2016) -
Audiologic evaluation in systemic lupus erythematosus patients and impact of hydroxychloroquine therapy
por: Samar Tharwat, et al.
Publicado: (2022)